Vaccine pro
Brussels-based vaccine developer Univac has appointed a new CEO. In March, Stefano Malvolti joined Univac from Gavi, the Vaccine Alliance, where he was responsible for rolling out the vaccine development programmes of the public-private partnership.
Before Gavi, he was Global Policy Director of Novartis Vaccines and prior to that, Director of Strategic Vaccines Supply at the Swiss non-profit organisation PATH. Malvolti holds an MPH from US-American Johns Hopkins Bloomberg School of Public Health and a Master in Business Economics from Milan-based Bocconi University.
Biocytogen Co Ltd
Draupnir Bio ApS